Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to approval will be clear as soon as the vaccine maker and the regulator agree on the ...

(Reuters) -Drugmaker Viatris beat Wall Street estimates for first-quarter profit and revenue on Thursday, helped by sales of its branded drugs in China. The company's shares, which rose over 4% in ...